Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2023 | Long-term safety and efficacy of eculizumab and ravulizumab in patients with PNH

In this video, Talha Munir, MBBS, Leeds Teaching Hospitals NHS Trust, Leeds, UK, comments on the safety and efficacy of eculizumab and ravulizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH), based on results from a UK experience. This interview took place at the 63rd Annual Scientific Meeting of the British Society for Haematology (BSH) 2023, held in Birmingham, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.